List of insiders holdings for NEOGENOMICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
JONES STEVEN C ASPEN SELECT HEALTHCARE LP Executive VP of Finance | 2015-11-27 15:04:22 | 961,251 3,600,378 | 4,561,629 | Form 4 |
VAN OORT DOUGLAS M Director | 2021-08-13 17:12:39 | 3,425,448 15,000 | 3,440,448 | Form 4 |
Smith Christopher M Chief Executive Officer | 2024-02-27 16:28:18 | 2,487,303 0 | 2,487,303 | Form 4 |
DENT MICHAEL T Director | 2014-12-08 09:50:41 | 437,500 1,384,150 | 1,821,650 | Form 4 |
JONES STEVEN C Director | 2021-01-11 17:24:53 | 93,666 1,296,233 | 1,389,899 | Form 4 |
GASPARINI ROBERT P Chief Science Officer | 2014-05-27 10:23:16 | 1,167,439 0 | 1,167,439 | Form 4 |
Mallon Mark Chief Executive Officer | 2022-03-03 19:59:06 | 866,844 0 | 866,844 | Form 4 |
Sherman Jeffrey Scott Chief Financial Officer | 2024-02-27 16:28:43 | 697,004 0 | 697,004 | Form 4 |
CARDOZA GEORGE President & COO, Lab Ops | 2022-03-03 19:58:07 | 662,557 20,000 | 682,557 | Form 4 |
Sikri Vishal President Advanced Diagnostics | 2024-02-27 16:27:34 | 623,127 0 | 623,127 | Form 4 |
ALBITAR MAHER Chief Medical Officer | 2017-05-30 17:05:54 | 420,000 60,692 | 480,692 | Form 4 |
Harris Melody President, Enterprise Ops | 2024-02-27 16:27:59 | 479,662 0 | 479,662 | Form 4 |
Stone Warren President, Clinical Services | 2024-02-27 16:29:36 | 446,902 0 | 446,902 | Form 4 |
Bonello William Chief Financial Officer | 2022-05-02 17:46:18 | 439,990 0 | 439,990 | Form 4 |
Robison William J Director | 2017-05-30 21:25:26 | 393,141 0 | 393,141 | Form 4 |
BRODIE STEVEN G. VP - Pharma Operations | 2018-10-24 18:36:55 | 373,953 0 | 373,953 | Form 4 |
Brown Douglas Matthew Chief Strategy Officer | 2022-04-04 19:07:12 | 315,598 0 | 315,598 | Form 4 |
Gilbert Halley E Chief Legal Officer | 2022-03-03 19:59:44 | 313,350 0 | 313,350 | Form 4 |
Olivo Alicia C General Counsel | 2024-02-27 16:29:14 | 284,650 0 | 284,650 | Form 4 |
Virag Sharon Chief Financial Officer | 2019-03-05 17:05:20 | 270,341 0 | 270,341 | Form 4 |
Kulkarni Shashikant Chief Scientific Officer | 2023-04-04 17:04:49 | 267,070 0 | 267,070 | Form 4 |
SHOVLIN ROBERT J. President, Clinical Services | 2021-05-27 18:23:32 | 264,442 0 | 264,442 | Form 4 |
PETERSON PETER M Director | 2012-06-07 11:06:28 | 34,500 212,760 | 247,260 | Form 4 |
Weiss Lawrence Martin Chief Medical Officer | 2021-04-26 17:48:52 | 215,224 0 | 215,224 | Form 4 |
DVONCH JEROME J Prinicpal Accounting Officer | 2011-05-02 14:39:20 | 215,167 0 | 215,167 | Form 3 |
Pedulla Denise E General Counsel | 2021-03-03 20:17:59 | 194,849 0 | 194,849 | Form 4 |
McKenzie Kathryn B Chief Sustainability/Risk Ofcr | 2022-01-12 18:50:42 | 193,840 0 | 193,840 | Form 4 |
HANNAH ALISON L. Director | 2023-08-14 17:41:33 | 155,452 0 | 155,452 | Form 4 |
ROSS STEVEN A CIO | 2018-05-10 17:53:07 | 138,168 0 | 138,168 | Form 4 |
BALLIET JENNIFER VP and Chief Culture Officer | 2021-12-30 18:03:44 | 136,052 0 | 136,052 | Form 4 |
Sholehvar David President, Clinical Services | 2022-08-03 17:45:43 | 135,414 0 | 135,414 | Form 4 |
Wallar Gina M President, Pharma Services | 2022-03-03 19:56:42 | 110,703 0 | 110,703 | Form 4 |
CROWTHER BRUCE K Director | 2023-08-14 17:38:17 | 102,405 0 | 102,405 | Form 4 |
HOREL ROBERT H. Vice President GM PathLogic | 2015-12-30 16:34:29 | 101,218 0 | 101,218 | Form 4 |
Morris Clive President of Inivata | 2021-12-30 18:05:23 | 95,137 0 | 95,137 | Form 4 |
TETRAULT LYNN A. Director | 2024-03-06 16:26:13 | 93,903 0 | 93,903 | Form 4 |
HIPP RAYMOND R Director | 2020-11-18 18:53:00 | 77,851 0 | 77,851 | Form 4 |
BYWATER STEPHANIE K Chief Compliance Officer | 2018-05-10 17:46:36 | 74,528 0 | 74,528 | Form 3 |
KANOVSKY STEPHEN M Director | 2023-08-14 17:39:45 | 69,756 0 | 69,756 | Form 4 |
Dieter Cynthia J Chief Accounting Officer | 2023-03-03 17:34:56 | 63,572 0 | 63,572 | Form 4 |
Kelly Michael Aaron Director | 2023-08-14 17:40:32 | 59,927 0 | 59,927 | Form 4 |
Machulcz Mark Alan Vice President of Operations | 2016-01-29 17:25:02 | 50,000 0 | 50,000 | Form 4 |
Johnson Kevin C Director | 2021-12-23 17:25:10 | 48,829 0 | 48,829 | Form 4 |
Aunan Greg D Chief Accounting Officer | 2023-05-24 17:30:13 | 44,052 0 | 44,052 | Form 3 |
Stahler Rachel A Director | 2022-06-14 20:42:01 | 42,379 0 | 42,379 | Form 4 |
MILLER MARYDAWN Vice President of IT | 2011-05-02 15:12:55 | 40,000 0 | 40,000 | Form 3 |
Perez David Brian Director | 2023-08-14 17:42:48 | 39,719 0 | 39,719 | Form 4 |
Daly David Director | 2022-06-14 20:41:42 | 33,006 0 | 33,006 | Form 4 |
Gunn Neil Director | 2023-08-14 17:35:36 | 19,689 0 | 19,689 | Form 4 |
Floegel Elizabeth Director | 2023-08-14 17:36:36 | 19,689 0 | 19,689 | Form 4 |
Zook Anthony P. Director | 2023-08-14 17:42:01 | 19,689 0 | 19,689 | Form 4 |
SMITS MARK W Chief Commercial Officer | 2011-05-20 14:22:44 | 6667 0 | 6667 | Form 4 |
GENERAL ELECTRIC CO GE Medical Systems Information Technologies Inc. Former 10% Owner | 2018-12-14 16:05:50 | 0 0 | 0 | Form 4 |
Murphy Kieran Pius Director | 2016-02-29 16:49:10 | 0 0 | 0 | Form 3 |
KINDERHOOK LP KINDERHOOK GP LLC KINDERHOOK PARTNERS LLC Shah Tushar CLEARMAN STEPHEN J See Remarks | 2013-07-30 16:28:01 | 0 0 | 0 | Form 13G |